Osaic Holdings’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $756 | Buy |
2,521
+2,490
| +8,032% | +$747 | ﹤0.01% | 6748 |
|
2025
Q1 | $293 | Sell |
31
-60
| -66% | -$567 | ﹤0.01% | 6933 |
|
2024
Q4 | $816 | Sell |
91
-4
| -4% | -$36 | ﹤0.01% | 6742 |
|
2024
Q3 | $6.09K | Hold |
95
| – | – | ﹤0.01% | 6008 |
|
2024
Q2 | $7.12K | Buy |
95
+78
| +459% | +$5.84K | ﹤0.01% | 5908 |
|
2024
Q1 | $2.07K | Hold |
17
| – | – | ﹤0.01% | 6298 |
|
2023
Q4 | $1.44K | Sell |
17
-1
| -6% | -$85 | ﹤0.01% | 6499 |
|
2023
Q3 | $1.43K | Buy |
18
+1
| +6% | +$79 | ﹤0.01% | 6593 |
|
2023
Q2 | $1.02K | Hold |
17
| – | – | ﹤0.01% | 6738 |
|
2023
Q1 | $745 | Hold |
17
| – | – | ﹤0.01% | 6921 |
|
2022
Q4 | $1K | Hold |
17
| – | – | ﹤0.01% | 6784 |
|
2022
Q3 | $2K | Hold |
17
| – | – | ﹤0.01% | 6672 |
|
2022
Q2 | $2K | Sell |
17
-1
| -6% | -$118 | ﹤0.01% | 6785 |
|
2022
Q1 | $3K | Hold |
18
| – | – | ﹤0.01% | 6602 |
|
2021
Q4 | $3K | Hold |
18
| – | – | ﹤0.01% | 6731 |
|
2021
Q3 | $5K | Sell |
18
-61
| -77% | -$16.9K | ﹤0.01% | 6487 |
|
2021
Q2 | $28K | Buy |
79
+54
| +216% | +$19.1K | ﹤0.01% | 5428 |
|
2021
Q1 | $12K | Buy |
25
+4
| +19% | +$1.92K | ﹤0.01% | 5734 |
|
2020
Q4 | $13K | Sell |
21
-10
| -32% | -$6.19K | ﹤0.01% | 5344 |
|
2020
Q3 | $11K | Buy |
+31
| New | +$11K | ﹤0.01% | 5188 |
|